Biomimetic Chromatography to Accelerate Drug Discovery: Part II

被引：0
|
作者：
Valko, Klara [1 ,2 ]
机构：
[1] Biomimet Chromatog Ltd, Stevenage, Herts, England
[2] UCL, Sch Pharm, London, England
来源：
LC GC NORTH AMERICA | 2018年 / 36卷 / 08期
关键词：
LEAD OPTIMIZATION; PHARMACOKINETICS; EFFICIENCY;
D O I：
暂无
中图分类号：
O65 [分析化学];
学科分类号：
070302 ; 081704 ;
摘要：
The biomimetic gradient retention time measurements on C18, immobilized artificial membrane (IAM), human serum albumin (HSA), and acid-glycoprotein (AGP) stationary phases can be used to characterize compounds partitioning into phospholipids and proteins. The data obtained can then be used in equations to estimate the in vivo plasma-tissue distribution of the compounds measured. The plasma protein binding, brain tissue binding, and in vivo drug efficiency can also be calculated using the biomimetic chromatographic data.
引用
收藏
页码：520 / 526
页数：7
相关论文
共 50 条
  • [21] Exploratory toxicology as an integrated part of drug discovery. Part II: Screening strategies
    Hornberg, Jorrit J.
    Laursen, Morten
    Brenden, Nina
    Persson, Mikael
    Thougaard, Annemette V.
    Toft, Dorthe B.
    Mow, Tomas
    DRUG DISCOVERY TODAY, 2014, 19 (08) : 1137 - 1144
  • [22] Advances in antiviral drug discovery and development: Part II: Advancements in antiviral drug development
    Saxena, Shailendra K.
    Mishra, Niraj
    Saxena, Rakhi
    FUTURE VIROLOGY, 2009, 4 (03) : 209 - 215
  • [23] Advances in Drug Discovery based on Genomics, Proteomics and Bioinformatics (Part II)
    Gupta, Satya Prakash
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2022, 22 (21) : 1750 - 1750
  • [24] Computational chemistry and computer-aided drug discovery: Part II
    Bajorath, Juergen
    FUTURE MEDICINAL CHEMISTRY, 2016, 8 (15) : 1799 - 1800
  • [25] Current Advances in Computational Approaches for Drug Discovery-Part II
    Gupta, Amit K.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (27) : 2267 - 2267
  • [26] Advances in Cheminformatics: Drug Discovery, Computational Toxicology and Nanomaterials (Part II)
    Afantitis, Antreas
    Melagraki, Georgia
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2015, 18 (04) : 333 - 334
  • [27] Lipophilicity and biomimetic properties to support drug discovery
    Tsopelas, Fotios
    Giaginis, Constantinos
    Tsantili-Kakoulidou, Anna
    EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (09) : 885 - 896
  • [28] Enantioselective chromatography in drug discovery
    Zhang, Y
    Wu, DR
    Wang-Iverson, DB
    Tymiak, AA
    DRUG DISCOVERY TODAY, 2005, 10 (08) : 571 - 577
  • [29] Chromatography advances drug discovery
    Flanagan, N
    GENETIC ENGINEERING NEWS, 2006, 26 (11): : 24 - +
  • [30] Leveraging Research Failures to Accelerate Drug Discovery and Development
    Yu, Helen
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (04) : 788 - 792
12345